Login
$CHRN
$14.63 -$0.14 (0.95%) Close

Ownership

13F as of Q2 2026 · 145.6M shares outstanding

Who owns CHRN?

By type of holder
Institutions 13.6% Insiders 86.4% Everyone else 0.0%
Concentration Top 10 holders own 268.9%
Applied Digital Corporation 95.8% · Chen Ying Cenly 78.8%
Institutional ownership
13.6%
+3.7 pts vs last qtr
Institutional holders
119
+24 vs last qtr
Net shares bought
+5.3M
by institutions in Q2 2026
New / sold out
45 / 21
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Paradigm Biocapital Advisors LP +888.5K
  • Jupiter Topco LLC NEW +849.3K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Janus Henderson Group PLC SOLD OUT −849.3K
  • Blackstone Inc. SOLD OUT −296.9K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Ekso Bionics Holdings Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2019–FY2026
+676.2%
+34.01% a year
Each share's claim on the business
−87.1%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $15.5M
over 8 fiscal years
Diluted shares, split-adjusted
17.3M78.7M140.1M2019: 17.9M shares'192020: 26.7M shares'202021: 45.7M shares'212022: 48.3M shares'222023: 51.7M shares'232024: 75.1M shares'242025: 138.2M shares'252026: 138.7M shares'26
Buybacks Stock-based comp
$0$1.3M$2.5M2019 buybacks: $02019 stock comp: $2.3M'192020 buybacks: $02020 stock comp: $2.4M'202021 buybacks: $02021 stock comp: $2.3M'212022 buybacks: $02022 stock comp: $2.5M'222023 buybacks: $02023 stock comp: $1.9M'232024 buybacks: $02024 stock comp: $1.4M'242025 buybacks: $02025 stock comp: $1.5M'252026 buybacks: $02026 stock comp: $1.3M'26

How patient are the owners?

Institutional shares by how long they've been held
5+ years12% 3–5 years0% 1–3 years28% Under 1 year60%
Quarterly turnover
35.4%
of institutional shares changed hands
Top 10 managers, median time held
3 quarters

Super Investors

Investment managers reporting CHRN on Form 13F
GS
Gilead Sciences, Inc.
Shares
5.0M
% of company
3.42%
Change vs last qtr
+471.7K (+10.5%)
Held since
2024
FC
Farallon Capital Management, L.L.C.
Shares
1.6M
% of company
1.10%
Change vs last qtr
+377.0K (+30.7%)
Held since
Q3 '25

28 more super investors behind a free account

See every manager holding Ekso Bionics Holdings Inc, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting CHRN on Form N-PORT; together they hold 1.4% of the company
VT
Position value
$11.4M
% of company
0.28%
% of the fund
0.00%
As of
June 30, 2026
VB
Valkyrie ETF Trust II
Position value
$7.41M
% of company
0.23%
% of the fund
2.16%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Ekso Bionics Holdings Inc and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
AD
Applied Digital Corporation
5%+ holder13D · 96.1%
Shares
139.5M
% of company
95.81%
Change vs last qtr
—
Held since
—
CY
Chen Ying Cenly
Insider
Shares
114.8M
% of company
78.83%
Change vs last qtr
—
Held since
—

15 more holders behind a free account

See every insider and 5%+ holder of Ekso Bionics Holdings Inc.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support